AAQL (Antiaging Quantum Living) EBIT: $-0.56 Mil (TTM As of Dec. 2025)

What is Antiaging Quantum Living EBIT?

Antiaging Quantum Living AAQL 28 EBIT is $-0.56 Mil as of Dec. 2025. GuruFocus rates AAQL with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Antiaging Quantum Living's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was $-0.27 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.56 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Antiaging Quantum Living's annualized ROC % for the quarter that ended in Dec. 2025 was -152.59%. Antiaging Quantum Living's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -181.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Antiaging Quantum Living's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -1.65%.

Antiaging Quantum Living (OTCPK:AAQL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Antiaging Quantum Living's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

	ROC % (Q: Dec. 2025 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2025 )	+	Invested Capital (Q: Dec. 2025 ))	/ count )
=	-1.088 * ( 1 - 0% )	/	( (0.804	+	0.622)	/ 2 )
=	-1.088	/	0.713
=	-152.59 %

where

	Invested Capital		(Q: Sep. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1.903	-	1.076	-	( 0.455	-	max(0, 1.199	-	1.222	+	0.455	))
=	0.804

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1.81	-	1.302	-	( 0.937	-	max(0, 1.382	-	1.268	+	0.937	))
=	0.622

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Antiaging Quantum Living's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2025 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2025		Q: Dec. 2025
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1.088	/	( ( (0.668 + max(-0.383, 0))	+	(0.529 + max(-1, 0)) )	/	2 )
=	-1.088	/	( ( 0.668	+	0.529 )	/	2 )
=	-1.088	/	0.5985
=	-181.79 %

where Working Capital is:

	Working Capital		(Q: Sep. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.468	+	0.072	+	0.227)	-	(1.076	+	0.074	+	0)
=	-0.383

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0.102	+	0.229)	-	(1.302	+	0.029	+	0)
=	-1

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Antiaging Quantum Living's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2025 )
	=	-0.56	/	34.015
	=	-1.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Antiaging Quantum Living EBIT Related Terms

Antiaging Quantum Living EBIT Historical Data

* Premium members only.

The historical data trend for Antiaging Quantum Living's EBIT can be seen below:

Antiaging Quantum Living EBIT Chart

Antiaging Quantum Living Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

EBIT

Get a 7-Day Free Trial

-0.07

-0.05

-0.04

-0.41

-0.72

Antiaging Quantum Living Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
EBIT	Get a 7-Day Free Trial															-0.20	-0.11	-0.13	-0.05	-0.27

AAQL vs NHTC, MOGU, KPEA: EBIT Comparison

For the Internet Retail subindustry, Antiaging Quantum Living's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antiaging Quantum Living EV-to-EBIT vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Antiaging Quantum Living's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Antiaging Quantum Living's EV-to-EBIT falls into.

Save Embed

28GF Score

Antiaging Quantum Living Inc AAQL

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Antiaging Quantum Living EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.56 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of $-0.56 Mil mean?

Antiaging Quantum Living (AAQL) has a EBIT of $-0.56 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Antiaging Quantum Living.

Is Antiaging Quantum Living's EBIT too high?

Antiaging Quantum Living's current EBIT is $-0.56 Mil. Overall, Antiaging Quantum Living has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does Antiaging Quantum Living's EBIT compare to NHTC and MOGU?

Antiaging Quantum Living's EBIT of $-0.56 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Retail - Cyclical company?

A good EBIT depends on the Retail - Cyclical industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Antiaging Quantum Living. Antiaging Quantum Living's current EBIT is $-0.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Antiaging Quantum Living stock overvalued right now?

Antiaging Quantum Living (AAQL) has a current EBIT of $-0.56 Mil. The current EBIT is $-0.56 Mil. Antiaging Quantum Living's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Antiaging Quantum Living (AAQL), the current EBIT is $-0.56 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Antiaging Quantum Living Business Description

Industry Consumer Cyclical Retail - Cyclical

Comparable Companies NHTC MOGU KPEA SBDS YJ JWEL WBUY WNW MI OCG AMZN BABA PDD XAMS:PRX MELI DASH HKSE:03690 SE EBAY JSE:NPN

Address 135-27 38th Avenue No.388, Flushing, NY, USA, 11354

Website https://www.aaql.com

Antiaging Quantum Living Inc is a health e-commerce company. The company distributes an extensive range of nutritional supplements, anti-aging and facial care products, personal care products, haircare and weight reduction products. It is active in the United States, China, and Africa.

28GF Score

Get the complete analysis for AAQL

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.00

Price

View AAQL Analysis

See EBIT data for all stocks →